Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

By Dr. Liji Thomas, MD Study shows that semaglutide not only aids in weight loss but also slashes heart failure risk by 76% ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

LifeVantage's shares surged 11% on the successful GLP-1 weight-management trial ... need to be suppressed to the same degree post-weight loss after 6 to 12 months, for example.

The quest for effective and safe weight loss solutions has long been a focus of medical research. In recent years, a novel approach involving GLP-1 injections has emerged as a potential game ...

The study involved 425 participants. Of these, 183 received surgery, while 242 received GLP-1 diabetes drugs, which also promote weight loss. Participants were followed for a median of 5.8 years.

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs, like Wegovy, have been approved for kids 12 and up and the number of ...